FDA allows young women in early drug tests
The FDA moves to include women of childbearing age in early testing of new medicines, reversing a 16 year ban. Pharmaceutical executives debate benefits and fetal risk, while Ruth Merkatz says most firms are on board. The rule aims to uncover sex differences in drug response to tailor therapies.
MENTIONED IN THIS ARTICLE
FDA
Boston
Food and Drug Administration
Women England Journal of Medicine
Robert Laverty
Bristol-Flyers
Squibb
Stots Reese
Hoffman-La Roche Inc
Ruth Merkatz
Merkatz
Also Mentioned on This Page
Filenes Basement
Syracuse
Carousel Center
Filene
American Express
Visa
MasterCard
Discover
The
Associated Press
Free “Living Trust
Syracuses
Buckley Rd
Susan L. Anderson
Suzan Anderson
Post Standard
Ms. Anderson
Estate Planning Council of
New York
Rise Wars
Scharbroll
Lindex